hen it comes to the cost of pharmaceuticals, companies like to play the blame game.

Drug makers carp that they must pay steep discounts to pharmacy benefit managers in order to win favorable coverage and ensure their medicines are prescribed. Pharmacy benefit managers deny pocketing unfair shares of the discounts, and argue drug makers offer discounts simply to boost sales — and could turn off the discount spigot at will. Patients, meanwhile, are caught in the middle.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.